Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations
Third-party testing
80,000+ Members with Sustained Results Join over 80,000 members who have achieved lasting health improvements with Levels
Outcomes: Studies reporting incident gastrointestinal cancers (colorectal, pancreatic, gastric, liver, or biliary tract cancers), either as primary, secondary, or safety out-comes
Proactive collagen support helps skin keep pace with fat reduction rather than trying to catch up afterward
Protects Your Heart Beyond Just Weight Loss GLP-1 medications offer remarkable protection for heart health beyond weight management and blood sugar control